Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Contraception study supports convenience, simplicity

27.02.2004


Women who used the once-a-week birth control patch, ORTHO EVRA® (norelgestromin/ethinyl estradiol transdermal system), were more likely to use their medication as directed than women who took a birth control pill, according to a study published in the current issue of Contraception.

"It’s not always easy, but it is very important for women using any birth control pill to take it at the same time every day to prevent unplanned pregnancy," said Vanessa Cullins, M.D. FACOG. "What’s exciting is that this study shows that the birth control patch is convenient and simple to use, and may be a better birth control option for women."

Oral birth control pills must be taken consistently and correctly to be effective, however an estimated 15 percent of oral birth control users say it is difficult to do so with the Pill. Inconsistent or incorrect use, i.e., missing one or more pills per cycle, can increase the risk of unplanned pregnancy and lead to abnormal bleeding, which is the leading cause of unscheduled physician visits. In the study, previously published Phase III data were analyzed to further explore compliance differences between ORTHO EVRA and an oral contraceptive. These results showed that the percentage of cycles with "perfect dosing," a measure of correct dosing of a birth control method, was significantly higher with the patch (88.7 percent) than oral contraceptives (79.2 percent).



Investigators pooled these data with new findings, which showed:


ORTHO EVRA users achieved perfect dosing in nearly 90 percent of total cycles. These rates were consistently high across all age groups.
Perfect dosing cycles were associated with significantly better contraceptive efficacy (p = .007) than imperfect dosing cycles, i.e., missing a dose and doubling up the next day.
ORTHO EVRA is indicated for the prevention of pregnancy. ORTHO EVRA is not for everyone. Women should speak with their healthcare professional about which birth control method is right for them.

The contraceptive patch contains hormones similar to those in birth control pills. Hormonal contraceptives are not for everyone. Most side effects of the contraceptive patch are not serious and those that are occur infrequently. Serious risks that can be life threatening includes blood clots, stroke or heart attacks, which are increased if you smoke cigarettes.

Cigarette smoking increases the risk of serious cardiovascular side effects, especially if you are over 35. Women who use hormonal contraceptives are strongly advised not to smoke. Some women should not use the contraceptive patch, including women who have blood clots, certain cancers, a history of heart attack or stroke, as well as those who are or may be pregnant. The contraceptive patch does not protect against HIV or other sexually transmitted diseases.


ORTHO EVRA was developed by Johnson & Johnson Pharmaceutical Research & Development, L.L.C. and is marketed by Ortho-McNeil Pharmaceutical, Inc. Ortho-McNeil is a pioneer and leader in contraception and women’s health care, offering the broadest range of prescription birth control options, including the first transdermal contraceptive patch, ten birth control pills, and diaphragms. The company also markets prescription pharmaceutical products in other therapeutic categories, including infectious disease, central nervous system, pain treatment, urology and migraine headache. For more information, visit www.orthoevra.com or www.ortho-mcneil.com.

Kevin Pchola | EurekAlert!
Further information:
http://www.orthoevra.com
http://www.ortho-mcneil.com

More articles from Social Sciences:

nachricht Amazingly flexible: Learning to read in your thirties profoundly transforms the brain
26.05.2017 | Max-Planck-Institut für Kognitions- und Neurowissenschaften

nachricht Fixating on faces
26.01.2017 | California Institute of Technology

All articles from Social Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Quantum thermometer or optical refrigerator?

23.06.2017 | Physics and Astronomy

A 100-year-old physics problem has been solved at EPFL

23.06.2017 | Physics and Astronomy

Equipping form with function

23.06.2017 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>